Constantinos Kilidireas

Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature

Elisabeth Andreadou, Elissavet Kemanetzoglou, Ch. Brokalaki et al. · Case Reports in Neurological Medicine · 2013 · 60 citations · Full text

Coincidental Association, Neurological Disorder, Clinical Neurology +20

Rituximab therapy in monoclonal IgM-related neuropathies

Constantinos Kilidireas, Nikolaos Karandreas, Lefki Mouselimi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 54 citations

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Greta Zoehner, Andrei Miclea, Anke Salmen et al. · Therapeutic Advances in Neurological Disorders · 2019 · 43 citations · Full text

Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up

Maria‐Eleftheria Evangelopoulos, Elisabeth Andreadou, Georgios Koutsis et al. · Journal of the Neurological Sciences · 2016 · 32 citations

Ophthalmology, Immunology, Six-year Follow-up +4

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials

Georgios Tsivgoulis, Aristeidis H. Katsanos, Dimitris Mavridis et al. · PLoS ONE · 2016 · 26 citations · Full text